Home
Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 25/02/04
Trade details
- Type
- Insider sale
- Amount
- $103,939.92
- Shares · price
- 5,166 sh · $20.12 a share
- Held after
- 122,708 sh
- Trade date
- 25/02/03
- Filed
- 25/02/04
- Days to filing
- 1 days
Sold 4.0% of holdings
- Share of holding sold
- 4.0%
Travere Therapeutics trades, last 26 weeks
What else happened in Travere Therapeutics around then
Filed or reported within 30 days of the trade day · 25/01/04~25/03/05Peter Heerma's recent trades
- Peter Heerma
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 planTravere Therapeutics
TVTX
$525.7K
8,282 sh
$525.7K
Filed 09/17
Traded 09/17
- Peter Heerma
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 planTravere Therapeutics
TVTX
$10.8M
172,717 sh
$10.8M
Filed 09/16
Traded 09/16
- Peter Heerma
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 planTravere Therapeutics
TVTX
$6.7M
102,190 sh
$6.7M
Filed 09/15
Traded 09/15
- Peter Heerma
SellTravere Therapeutics
SellTravere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
- Peter Heerma
Planned saleTravere Therapeutics
Planned saleTravere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/05
Traded 05/05